Wesley T. Kerr

Struggling behavior during restraint is regulated by stress experience

Restraint elicits a number of physiological stress responses that can be increased or decreased in magnitude based on prior stress history. For instance, repeated exposure to restraint leads to habituation of hypothalamic-pituitary-adrenal (HPA) activation to restraint. In contrast, acute restraint after a different repeated stressor leads to facilitation of HPA activity to the novel stress. Acute restraint also elicits a variety of behaviors, including struggling, but the effect of prior stress in regulating behavioral responses to restraint is not clear. The goal of the present studies was to assess struggling during restraint with or without a prior history of repeated stress. Using automated behavioral analysis software (EthoVision), we quantified struggling during restraint. We found that acutely restrained rats exhibited vigorous struggling behavior that declined during a single restraint period. Repeated restraint lead to habituated struggling behavior, whereas acute restraint after repeated swim elicited facilitated struggling behavior. These effects on struggling were found alongside expected differences in HPA activity. Removing stress-induced increases in corticosterone via adrenalectomy did not significantly affect struggling responses to restraint. Overall, restraint-induced struggling appears to be regulated in a manner similar to HPA responses to restraint, but is not dictated by adrenal hormones.

Distinguishing Conjoint and Independent Neural Tuning for Stimulus Features With fMRI Adaptation

A central focus of cognitive neuroscience is identification of the neural codes that represent stimulus dimensions. One common theme is the study of whether dimensions, such as color and shape, are encoded independently by separate pools of neurons or are represented by neurons conjointly tuned for both properties. We describe an application of functional magnetic resonance imaging (fMRI) adaptation to distinguish between independent and conjoint neural representations of dimensions by examining the neural signal evoked by changes in one versus two stimulus dimensions and considering the metric of two-dimension additivity. We describe how a continuous carry-over paradigm may be used to efficiently estimate this metric. The assumptions of the method are examined as are optimizations. Finally, we demonstrate that the method produces the expected result for fMRI data collected from ventral occipitotemporal cortex while subjects viewed sets of shapes predicted to be represented by conjoint or independent neural tuning.

Computer-Aided Diagnosis and Localization of Lateralized Temporal Lobe Epilepsy Using Interictal FDG-PET.

Interictal FDG-PET (iPET) is a core tool for localizing the epileptogenic focus, potentially before structural MRI, that does not require rare and transient epileptiform discharges or seizures on EEG. The visual interpretation of iPET is challenging and requires years of epilepsy-specific expertise. We have developed an automated computer-aided diagnostic (CAD) tool that has the potential to work both independent of and synergistically with expert analysis. Our tool operates on distributed metabolic changes across the whole brain measured by iPET to both diagnose and lateralize temporal lobe epilepsy (TLE). When diagnosing left TLE (LTLE) or right TLE (RTLE) vs. non-epileptic seizures (NES), our accuracy in reproducing the results of the gold standard long term video-EEG monitoring was 82% [95% confidence interval (CI) 69–90%] or 88% (95% CI 76–94%), respectively. The classifier that both diagnosed and lateralized the disease had overall accuracy of 76% (95% CI 66–84%), where 89% (95% CI 77–96%) of patients correctly identified with epilepsy were correctly lateralized. When identifying LTLE, our CAD tool utilized metabolic changes across the entire brain. By contrast, only temporal regions and the right frontal lobe cortex, were needed to identify RTLE accurately, a finding consistent with clinical observations and indicative of a potential pathophysiological difference between RTLE and LTLE. The goal of CADs is to complement – not replace – expert analysis. In our dataset, the accuracy of manual analysis (MA) of iPET (∼80%) was similar to CAD. The square correlation between our CAD tool and MA, however, was only 30%, indicating that our CAD tool does not recreate MA. The addition of clinical information to our CAD, however, did not substantively change performance. These results suggest that automated analysis might provide clinically valuable information to focus treatment more effectively.

Implementation of Machine Learning for Classifying Hemiplegic Gait Disparity through Use of a Force Plate

The synergy of gait analysis tools with machine learning enables the capacity to classify disparity existing in hemiplegic gait. Hemiplegic gait is characterized by an affected leg and unaffected leg, which can be quantified by the measurement of a force plate. The characteristic features of the force plate recording for gait consist of a two local maxima that represent the braking phase and push off phase of stance and their associated parameters. The quantified features of a hemiplegic pair of affected leg and unaffected leg force plate recordings are intuitively disparate. Logistic regression achieves 100% classification between an affected and unaffected hemiplegic leg pair based on the feature set of the force plate data.

Automated diagnosis of epilepsy using EEG power spectrum

Interictal electroencephalography (EEG) has clinically meaningful limitations in its sensitivity and specificity in the diagnosis of epilepsy because of its dependence on the occurrence of epileptiform discharges. We have developed a computer‐aided diagnostic (CAD) tool that operates on the absolute spectral energy of the routine EEG and has both substantially higher sensitivity and negative predictive value than the identification of interictal epileptiform discharges. Our approach used a multilayer perceptron to classify 156 patients admitted for video‐EEG monitoring. The patient population was diagnostically diverse; 87 were diagnosed with either generalized or focal seizures. The remainder of the patients were diagnosed with nonepileptic seizures. The sensitivity was 92% (95% confidence interval [CI] 85–97%) and the negative predictive value was 82% (95% CI 67–92%). We discuss how these findings suggest that this CAD can be used to supplement event‐based analysis by trained epileptologists.

Diagnostic delay in psychogenic seizures and the association with anti-seizure medication trials

PURPOSE The average delay from first seizure to diagnosis of psychogenic non-epileptic seizures (PNES) is over 7 years. The reason for this delay is not well understood. We hypothesized that a perceived decrease in seizure frequency after starting an anti-seizure medication (ASM) may contribute to longer delays, but the frequency of such a response has not been well established. METHODS Time from onset to diagnosis, medication history and associated seizure frequency was acquired from the medical records of 297 consecutive patients with PNES diagnosed using video-electroencephalographic monitoring. Exponential regression was used to model the effect of medication trials and response on diagnostic delay. RESULTS Mean diagnostic delay was 8.4 years (min 1 day, max 52 years). The robust average diagnostic delay was 2.8 years (95% CI: 2.2-3.5 years) based on an exponential model as 10 to the mean of log10 delay. Each ASM trial increased the robust average delay exponentially by at least one third of a year (Wald t=3.6, p=0.004). Response to ASM trials did not significantly change diagnostic delay (Wald t=-0.9, p=0.38). CONCLUSION Although a response to ASMs was observed commonly in these patients with PNES, the presence of a response was not associated with longer time until definitive diagnosis. Instead, the number of ASMs tried was associated with a longer delay until diagnosis, suggesting that ASM trials were continued despite lack of response. These data support the guideline that patients with seizures should be referred to epilepsy care centers after failure of two medication trials.

Single trial decoding of belief decision making from EEG and fMRI data using independent components features

The complex task of assessing the veracity of a statement is thought to activate uniquely distributed brain regions based on whether a subject believes or disbelieves a given assertion. In the current work, we present parallel machine learning methods for predicting a subjects decision response to a given propositional statement based on independent component (IC) features derived from EEG and fMRI data. Our results demonstrate that IC features outperformed features derived from event related spectral perturbations derived from any single spectral band, yet were similar to accuracy across all spectral bands combined. We compared our diagnostic IC spatial maps with our conventional general linear model (GLM) results, and found that informative ICs had significant spatial overlap with our GLM results, yet also revealed unique regions like amygdala that were not statistically significant in GLM analyses. Overall, these results suggest that ICs may yield a parsimonious feature set that can be used along with a decision tree structure for interpretation of features used in classifying complex cognitive processes such as belief and disbelief across both fMRI and EEG neuroimaging modalities.

The utility of data-driven feature selection: Re: Chu et al. 2012

The recent Chu et al. (2012) manuscript discusses two key findings regarding feature selection (FS): (1) data driven FS was no better than using whole brain voxel data and (2) a priori biological knowledge was effective to guide FS. Use of FS is highly relevant in neuroimaging-based machine learning, as the number of attributes can greatly exceed the number of exemplars. We strongly endorse their demonstration of both of these findings, and we provide additional important practical and theoretical arguments as to why, in their case, the data-driven FS methods they implemented did not result in improved accuracy. Further, we emphasize that the data-driven FS methods they tested performed approximately as well as the all-voxel case. We discuss why a sparse model may be favored over a complex one with similar performance. We caution readers that the findings in the Chu et al. report should not be generalized to all data-driven FS methods.

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation

In the present work, we demonstrate a method for concurrent collection of EEG/fMRI data. In our setup, EEG data are collected using a high-density 256-channel sensor net. The EEG amplifier itself is contained in a field isolation containment system (FICS), and MRI clock signals are synchronized with EEG data collection for subsequent MR artifact characterization and removal. We demonstrate this method first for resting state data collection. Thereafter, we demonstrate a protocol for EEG/fMRI data recording, while subjects listen to a tape asking them to visualize that their left hand is immersed in a cold-water bath and referred to, here, as the cold glove paradigm. Thermal differentials between each hand are measured throughout EEG/fMRI data collection using an MR compatible temperature sensor that we developed for this purpose. We collect cold glove EEG/fMRI data along with simultaneous differential hand temperature measurements both before and after hypnotic induction. Between pre and post sessions, single modality EEG data are collected during the hypnotic induction and depth assessment process. Our representative results demonstrate that significant changes in the EEG power spectrum can be measured during hypnotic induction, and that hand temperature changes during the cold glove paradigm can be detected rapidly using our MR compatible differential thermometry device.

Diagnostic implications of review-of-systems questionnaires to differentiate epileptic seizures from psychogenic seizures

OBJECTIVE Early and accurate diagnosis of patients with psychogenic nonepileptic seizures (PNES) leads to appropriate treatment and improves long-term seizure prognosis. However, this is complicated by the need to record seizures to make a definitive diagnosis. Suspicion for PNES can be raised through knowledge that patients with PNES have increased somatic sensitivity and report more positive complaints on review-of-systems questionnaires (RoSQs) than patients with epileptic seizures. If the responses on the RoSQ can differentiate PNES from other seizure types, then these forms could be an early screening tool. METHODS Our dataset included all patients admitted from January 2006 to June 2016 for video-electroencephalography at UCLA. RoSQs prior to May 2015 were acquired through retrospective chart review (n=405), whereas RoSQs from subsequent patients were acquired prospectively (n=190). Controlling for sex and number of comorbidities, we used binomial regression to compare the total number of symptoms and the frequency of specific symptoms between five mutually exclusive groups of patients: epileptic seizures (ES), PNES, physiologic nonepileptic seizure-like events (PSLE), mixed PNES plus ES, and inconclusive monitoring. To determine the diagnostic utility of RoSQs to differentiate PNES only from ES only, we used multivariate logistic regression, controlling for sex and the number of medical comorbidities. RESULTS On average, patients with PNES or mixed PNES and ES reported more than twice as many symptoms than patients with isolated ES or PSLE (p<0.001). The prospective accuracy to differentiate PNES from ES was not significantly higher than naïve assumption that all patients had ES (76% vs 70%, p>0.1). DISCUSSION This analysis of RoSQs confirms that patients with PNES with and without comorbid ES report more symptoms on a population level than patients with epilepsy or PSLE. While these differences help describe the population of patients with PNES, the consistency of RoSQ responses was neither accurate nor specific enough to be used solely as an early screening tool for PNES. Our results suggest that the RoSQ may help differentiate PNES from ES only when, based on other information, the pre-test probability of PNES is at least 50%.